Sanofi stock rises as Dupixent shows benefit in lung disease smokers, meets phase 3 goals
JHVEPhoto Sanofi (NASDAQ:SNY) and Regeneron Pharmaceuticals' (NASDAQ:REGN) Dupixent met the main goal and all key secondary goals of a phase ...
JHVEPhoto Sanofi (NASDAQ:SNY) and Regeneron Pharmaceuticals' (NASDAQ:REGN) Dupixent met the main goal and all key secondary goals of a phase ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.